The race to find a vaccine or treatment to stop Ebola. As the Ebola virus outbreak continues to rage in West Africa, the pressure is on to fast-track drug research that could potentially stop or slow its spread.
Last week, the National Institute of Allergy and Infectious Disease (NIAID), a division of the National Institutes of Health, announced plans to expedite research on a vaccine against Ebola that's been shown to be effective in primates. The clinical trial on humans may begin as early as next month. "We tested it in monkeys, it looks very good, it protects monkeys completely from challenge with Ebola. They don't get sick and they don't die, whereas unvaccinated monkeys all do," Dr. Anthony Fauci, director of NIAID, told "CBS This Morning" on Monday. Home. Markers « COPICMARKER.COM.